1. Home
  2. |Insights
  3. |GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

Client Alert | less than 1 min read | 11.18.16

Last month, GAO issued a report on strategic sourcing that addresses how successful the Federal Strategic Sourcing Initiative (FSSI) program has been to date. While the report found that, from FY2011-15, agencies reported spending almost $2 billion through the FSSI and claimed $470 million in savings, the report also found that “agencies’ low use of the FSSIs … diminished the potential savings that could have been achieved” – an underutilization that GAO attributed partially to the Strategic Sourcing Leadership Council agencies directing only “10 percent of their collective spending to the FSSIs[,]” with GAO calling for more aggressive targets to be set.

Insights

Client Alert | 3 min read | 05.26.26

pH, Prosecution History Estoppel, and Patent Scope: Three Lessons from the Federal Circuit's Latest Hatch-Waxman Ruling

On May 13, 2026, the U.S. Court of Appeals for the Federal Circuit affirmed a district court judgment of no infringement in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc., No. 24-1641. The decision offers important guidance for patent holders and generic manufacturers on the role of industry standards in interpreting scientific terminology during claim construction, prosecution history estoppel, and the disclosure-dedication rule....